NIKANG THERAPEUTICS
NiKang Therapeutics is an early-stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs. Its discovery approach is informed by target structure biology and capitalizes on structure-based drug design enabling a rapid and efficient discovery and development of proprietary drug candidates with the most desirable pharmacological features into clinical studies.
NIKANG THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.nikangtx.com
Total Employee:
11+
Status:
Active
Contact:
302 644 5450
Email Addresses:
[email protected]
Total Funding:
250 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy ThemePunch Starfield Technologies
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Exuma Biotech
EXUMA Biotech is a clinical-stage biotechnology company that focuses on discovering and developing CAR-T cell products for solid tumors.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
EcoR1 Capital
EcoR1 Capital investment in Series C - NiKang Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series C - NiKang Therapeutics
Pavilion Capital
Pavilion Capital investment in Series C - NiKang Therapeutics
RA Capital Management
RA Capital Management investment in Series C - NiKang Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series C - NiKang Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - NiKang Therapeutics
PFM Health Sciences
PFM Health Sciences investment in Series C - NiKang Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - NiKang Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series C - NiKang Therapeutics
Invus
Invus investment in Series C - NiKang Therapeutics
Official Site Inspections
http://www.nikangtx.com Semrush global rank: 5.57 M Semrush visits lastest month: 1.52 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
